ramipril

Generic: ramipril

Labeler: lupin pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ramipril
Generic Name ramipril
Labeler lupin pharmaceuticals, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

ramipril 1.25 mg/1

Manufacturer
Lupin Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 68180-588
Product ID 68180-588_c73b9a08-9128-464e-9a01-040977af1368
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077626
Listing Expiration 2026-12-31
Marketing Start 2008-06-10

Pharmacologic Class

Established (EPC)
angiotensin converting enzyme inhibitor [epc]
Mechanism of Action
angiotensin-converting enzyme inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68180588
Hyphenated Format 68180-588

Supplemental Identifiers

RxCUI
198188 198189 261962 845488
UPC
0368180589099 0368180591092 0368180590095
UNII
L35JN3I7SJ
NUI
N0000175562 N0000000181

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ramipril (source: ndc)
Generic Name ramipril (source: ndc)
Application Number ANDA077626 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1.25 mg/1
source: ndc
Packaging
  • 16 HOW SUPPLIED/STORAGE AND HANDLING Ramipril capsules USP are available in 2.5 mg, 5 mg, and 10 mg hard gelatin capsules. Descriptions of Ramipril capsules USP are summarized below. Ramipril capsules USP, 2.5 mg are: Size "4" capsules with orange cap, imprinted with 'LUPIN' in black ink and orange body imprinted with 'RAMIPRIL 2.5 mg' in black ink, containing white to off-white powder. NDC 68180-589-10 bottles of 90 NDC 68180-589-01 bottles of 100 NDC 68180-589-02 bottles of 500 Ramipril capsules USP, 5 mg are: Size "4" capsules with red cap, imprinted with 'LUPIN' in black ink and red body imprinted with 'RAMIPRIL 5 mg' in black ink, containing white to off-white powder. NDC 68180-590-10 bottles of 90 NDC 68180-590-01 bottles of 100 NDC 68180-590-02 bottles of 500 Ramipril capsules USP, 10 mg are: Size "4" capsules with light blue cap, imprinted with 'LUPIN' in black ink and light blue body imprinted with 'RAMIPRIL 10 mg' in black ink, containing white to off-white powder. NDC 68180-591-10 bottles of 90 NDC 68180-591-01 bottles of 100 NDC 68180-591-02 bottles of 500 Dispense in light-resistant, tight container with child-resistant closure. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].
  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Ramipril Capsules 2.5 mg – Bottle of 90s NDC 68180-589-09 bottles of 90 Ramipril Capsules 2.5 mg – Bottle of 90s NDC 68180-589-10 bottles of 90 Ramipril Capsules 5 mg – Bottle of 90s NDC 68180-590-09 bottles of 90 Ramipril Capsules 5 mg – Bottle of 90s NDC 68180-590-10 bottles of 90 Ramipril Capsules 10 mg – Bottle of 90s NDC 68180-591-09 bottles of 90 Ramipril Capsules 10 mg – Bottle of 90s NDC 68180-591-10 bottles of 90 Ramipril Capsules 2.5 mg – Bottle of 90s NDC 68180-589-09 bottles of 90 Ramipril Capsules 5 mg – Bottle of 90s NDC 68180-590-09 bottles of 90 Ramipril Capsules 10 mg – Bottle of 90s NDC 68180-591-09 bottles of 90 Ramipril Capsules 1.25 mg – Bottle of 90s NDC 68180-588-09 bottles of 90 Bottle Label 2.5 mg Bottle Label 2.5 mg Bottle Label - 5 mg Bottle Label - 5 mg Bottle Label - 10 mg Bottle Label - 10 mg Bottle Label - 2.5 mg Bottle Label - 5 mg Bottle Label -10 mg Bottle Label -1.5 mg
source: label

Packages (0)

No package records.

Ingredients (1)

ramipril (1.25 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c73b9a08-9128-464e-9a01-040977af1368", "openfda": {"nui": ["N0000175562", "N0000000181"], "upc": ["0368180589099", "0368180591092", "0368180590095"], "unii": ["L35JN3I7SJ"], "rxcui": ["198188", "198189", "261962", "845488"], "spl_set_id": ["a8cdec12-81d1-4ef4-82c0-d05d93c37a07"], "pharm_class_epc": ["Angiotensin Converting Enzyme Inhibitor [EPC]"], "pharm_class_moa": ["Angiotensin-converting Enzyme Inhibitors [MoA]"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "Ramipril", "product_id": "68180-588_c73b9a08-9128-464e-9a01-040977af1368", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]"], "product_ndc": "68180-588", "generic_name": "Ramipril", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ramipril", "active_ingredients": [{"name": "RAMIPRIL", "strength": "1.25 mg/1"}], "application_number": "ANDA077626", "marketing_category": "ANDA", "marketing_start_date": "20080610", "listing_expiration_date": "20261231"}